Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: A prospective, randomized study

Fertility and Sterility

Volumn 78, Issue 6, 2002, Pages 1268-1271

  Orvieto, Raoul ^a,b   Kerner, Ram ^a,b   Krissi, Haim ^a,b   Ashkenazi, Jacob ^a,b   Rafael, Zion Ben ^a,b   Bar Hava, Itai ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; GONADORELIN DERIVATIVE; LEUPRORELIN; TRIPTORELIN;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; HYPOPHYSIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NIDATION; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE PROCEDURES;

ADULT; DELAYED-ACTION PREPARATIONS; EMBRYO IMPLANTATION; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; LEUPROLIDE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; TRIPTORELIN;

EID: 0036901605     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04262-0     Document Type: Article

References (21)

1. Meldrum D.R., Wisot A., Hamilton F., Gutlay A.L., Kempton W.F., Huynh D. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril. 51:1989;445-459.
2. Hughes E.G., Fedorkow D.M., Daya S., Sagle M., Van de Koppel P., Collins J.A. The routine use of gonadotropin-releasing agonists to in vitro fertilization and gamete intra-fallopian transfer a meta-analysis of randomized controlled trials . Fertil Steril. 58:1992;888-896.
3. Tan S.L. Luteinizing hormone-releasing hormone agonist for ovarian stimulation in assisted reproduction. Curr Opin Obstet Gynecol. 6:1994;166-172.
4. Daya S. Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. 2001;The Cochrane Library. Issue 2.
5. Balasch J., Jove I.C., Moreno V., Civico S., Puerto B., Vanrell J.A. The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program. Fertil Steril. 58:1992;991-994.
6. Tarlatzis B.C., Grimbizis G., Pournaropoulos F., Bontis J., Lagos S., Pados G., et al. Evaluation of two gonadotrophin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques. J Assist Reprod Genet. 11:1994;85-91.
7. Porcu E., Filicori M., Dal Parto L., Fabbin R., Serachioli R., Colombi C., et al. Comparison between depot leuprorelin and daily buserelin in IVF. J Assist Reprod Genet. 12:1995;15-19.
8. Cheung T.H., Lo K.W., Lam C.W., Lau W., Lam P.K. A crossover study of triptorelin and leuprorelin acetate. Fertil Steril. 74:2000;299-305.
9. Vauthier-Brouzes D., Lefebvre G. Comparison of 3 long ovarian stimulation protocols for in vitro fertilization using a delayed acting GnRH analogue. Contracept Fertil Sex. 21:(3):1993;209-212.
10. Neuspiller F., Levy M., Remohi J., Ruiz A., Simon C., Pellicer A. The use of long and short acting forms of gonadotrophin releasing hormone analogues in women undergoing oocyte donation. Hum Reprod. 13:1998;1148-1151.
11. Parinaud J., Oustry P., Perineau M., Reme J.M., Monrozies X., Pontonnier G. Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program. Fertil Steril. 57:1992;1265-1268.
12. Dada T., Salha O., Baillie H.S., Sharma V. A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme a prospective randomized study . Hum Reprod. 14:1999;288-293.
13. Gianaroli L., Ferraretti A.P., Feliciani E., Tabanelli C., Magli C., Fertini D. Prospective randomized study of D-Trp-6-LHRH versus buserelin in long desensitizing protocols for medically assisted conception cycles. Hum Reprod. 9:1994;220-225.
14. Imai A., Ohno T., Iida K., Fuseya T., Furui T., Tamaya T. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. Gynecol Oncol. 55:1994;144-148.
15. Casan E.M., Raga F., Kruessel J.S., Wen Y., Nezhat C., Polan M.L. Immunoreactive gonadotropin-releasing hormone expression in cycling human endometrium of fertile patients. Fertil Steril. 70:1998;102-106.
16. Raga F., Casa E.M., Kruessel J.S., Wen Y., Huang H.Y., Nezhat C., et al. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod. 59:1998;661-669.
17. Seshagiri P.B., Terasawa E., Hern J.P. Secretion of gonadotrophin-releasing hormone by peri-implantation embryos of the rhesus monkey comparison with the secretion of chorionic gonadotrophin . Hum Reprod. 9:1994;1300-1307.
18. Fujii S., Sato S., Fukui A., Kimura H., Kasai G., Saito Y. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF. Hum Reprod. 16:2001;1671-1675.
19. Testart J., Lefevre B., Gougeon A. Effects of gonadotrophin releasing hormone agonists (GnRHa) on follicle and oocyte quality. Hum Reprod. 8:1993;511-518.
20. Tolis G., Comaru-Schally A.M., Mehta A.E., Schally A.V. Failure to interrupt established pregnancy in humans by D-tryptophan-6-luteinizing hormone-releasing hormone. Fertil Steril. 36:1981;241-242.
21. Gartner B., Moreno C., Marinaro A., Remohi J., Simon C., Pellicer A. Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilisation cycle. Hum Reprod. 12:1997;2557-2559.